The Centers for Medicare & Medicaid Services (CMS) recently published two proposed rules that could affect Medicare reimbursement for cardiology services. On July 22, 2024, CMS published the Calendar Year (CY) 2025 Hospital...more
The Centers for Medicare & Medicaid Services (CMS) recently released data on its 2023 settlements of voluntary self-disclosures related to past violations or potential violations of the physician self-referral law (the Stark...more
Applicable Provider Types: Hospice; Home Health Agency -
Is Your Entity in Compliance?
The Centers for Medicare & Medicaid Services (CMS) finalized and expanded its so-called 36-month rule with certain changes...more
On Nov. 13, 2023, the Centers for Medicare & Medicaid Services (CMS) finalized its 2024 home health rule, which includes certain changes applicable to Medicare-enrolled hospices. This rule initially was proposed June 30,...more
The Centers for Medicare & Medicaid Services (CMS) recently released data on its 2021 and 2022 settlements of voluntary self-disclosures related to past violations or potential violations of the physician self-referral law...more
The Centers for Medicare & Medicaid Services (CMS) proposed new rules intended to strengthen the integrity of the Medicare hospice enrollment process due to CMS’ view of fraud and abuse concerns in the hospice industry....more
On July 26, 2022, Judge Jeremy D. Kernodle of the U.S. District Court for the Eastern District of Texas set aside a portion of the interim final rule implementing the No Surprises Act’s (NSA) independent dispute resolution...more
Newsworthy Highlights -
D.C. Passes Emergency Bill Allowing Adults to Self-Prescribe Medical Marijuana. Recently, D.C. councilmembers unanimously voted to pass, and D.C. Mayor Muriel Bowser signed, an emergency bill...more
Newsworthy Highlights -
Supreme Court Refuses to Hear Medical Cannabis Workers’ Compensation Case. On June 21, 2022, the U.S. Supreme Court denied two petitions for a writ of certiorari brought by injured workers in...more
Newsworthy Highlights -
FDA Continues CBD Warnings; Sends Letters to Companies Selling CBD Products for Food-Producing Animals. On May 26, 2022, the U.S. Food and Drug Administration (FDA) issued warning letters to four...more
Newsworthy Highlights -
FDA Warns Companies Selling Delta-8 Products. On May 4, 2022, the U.S. Food and Drug Administration issued warning letters to five companies for selling products labeled as containing delta-8...more
Newsworthy Highlights -
Virginia Access to Medical Cannabis and Delta-8 Ban Moving Forward. Virginia Gov. Glenn Youngkin approved Senate Bill 591, which eliminates existing requirements for medical cannabis patients to...more
The No Surprises Act (NSA) went into effect Jan. 1, 2022, with the goal of protecting consumers from unexpected medical bills. The NSA places numerous obligations on certain healthcare providers, facilities and providers of...more
Newsworthy Highlights -
MORE Act Passes House Again. On April 1, 2022, the U.S. House of Representatives again passed the Marijuana Opportunity Reinvestment and Expungement Act (the MORE Act), a proposed piece of federal...more
Connecticut Accepts Unlimited Applications Through Cannabis License Lottery In February 2022, Connecticut’s Department of Consumer Protection (DCP) started accepting applications for certain cannabis licenses for a period of...more
Newsworthy Highlights -
New Hampshire Opens Door to Accommodating Use of Medical Marijuana. On Jan. 14, 2022, a New Hampshire Supreme Court ruling opened the door to potentially allow cannabis prescribed in accordance with...more
On Feb. 23, 2022, the U.S. District Court for the Eastern District of Texas granted a motion for summary judgment in favor of the Texas Medical Association and Dr. Adam Corley, striking down a portion of an interim final rule...more
Newsworthy Highlights -
Pennsylvania Department of Health Bans Certain Vaporized Products. The Pennsylvania Department of Health Office of Medical Marijuana recently banned any cannabis product containing ingredients not...more